ATRI Atrion Corporation

Atrion Reports Fourth Quarter and Full Year 2022 Results

Atrion Reports Fourth Quarter and Full Year 2022 Results

ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2022 and the full year 2022.

Revenues for the fourth quarter of 2022 totaled $42.9 million compared to $40.3 million for the same period in 2021. For the quarter ended December 31, 2022, operating income was $8.8 million, up $967 thousand over the comparable 2021 period, and net income was $8.3 million, up $195 thousand over the same period in 2021. Fourth quarter 2022 diluted earnings per share were $4.70 compared to $4.50 for the fourth quarter of 2021. For the full year 2022 compared to the full year 2021, revenues increased to $183.5 million from $165.0 million, net income was $35.0 million versus $33.1 million, and diluted earnings per share were $19.56 compared to $18.18.

Commenting on the results of the quarter and the full year compared to prior year periods, David Battat, President and CEO, stated, “We are very pleased with the results of the quarter when, despite supply disruptions, revenues were up 6% to an all-time record amount for a fourth quarter. For the full year 2022, revenues increased 11%, also to a new record level for the Company.” Mr. Battat continued, “Progressively higher costs for labor and raw materials resulted in a 1% drop in gross profit margin, with 2022 concluding at 41% compared to 42% in 2021. Nevertheless, operating income was up 12% for the just-ended quarter and 10% for the year. Net income was up by 2% in the fourth quarter and 6% for the year, adversely impacted by weaker performance in our investment portfolio. Earnings per share were up 8% for the full year, with fewer outstanding shares following the repurchase of 18,828 shares in the fourth quarter at an average cost per share of $603.19 and total repurchases during the full year of 42,568 shares at an average cost per share of $605.78. We remain debt free, despite investing heavily in our future growth. In addition to our ongoing program of aggressive investment in new products and automation, over the last few years we committed $41 million for a new company-wide ERP system and a significant expansion of our Florida facility to meet anticipated future demand.”

Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is

Contact:

Jeffery Strickland

Vice President and Chief Financial Officer

(972) 390-9800





ATRION CORPORATION


UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

 Three Months Ended

December 31,
 Twelve Months Ended

December 31,
  2022   2021   2022   2021 
Revenues$42,855  $40,293  $183,506  $165,009 
Cost of goods sold 24,681   22,917   107,602   95,637 
Gross profit 18,174   17,376   75,904   69,372 
Operating expenses 9,369   9,538   36,217   33,330 
Operating income 8,805   7,838   39,687   36,042 
        
Interest and dividend income  349    163    988    843 
Other investment income (loss)  (366)   625    (150)   1,477 
Other income  --    --    92    67 
Income before income taxes 8,788   8,626   40,617   38,429 
Income tax provision  (466)  (499)  (5,609)  (5,374)
Net income $8,322  $8,127  $35,008  $33,055 
        
Income per basic share$4.70  $4.51  $19.59  $18.22 
        
Weighted average basic shares outstanding 1,770   1,801   1,787   1,814 
        
Income per diluted share$4.70  $4.50  $19.56  $18.18 
        
Weighted average diluted shares outstanding 1,771   1,806   1,790   1,818 





ATRION CORPORATION


CONSOLIDATED BALANCE SHEETS

(In thousands)

 Dec. 31, Dec. 31,
ASSETS 2022   2021 
 (Unaudited)  
Current assets:   
Cash and cash equivalents$4,731  $32,264 
Short-term investments 21,152   29,059 
Total cash and short-term investments 25,883   61,323 
Accounts receivable 23,951   21,023 
Inventories 65,793   50,778 
Prepaid expenses and other 3,770   3,447 
Total current assets 119,397   136,571 




Long-term investments
 8,669   19,423 




Property, plant and equipment, net
 123,754   97,972 
Other assets 12,892   13,298 
    
 $264,712  $267,264 
    
LIABILITIES AND STOCKHOLDERS’ EQUITY   
    
Current liabilities 18,098   13,346 
Line of credit --   -- 
Other non-current liabilities 7,073   9,622 
Stockholders’ equity 239,541    244,296  
    
 $264,712  $267,264 



EN
27/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Atrion Corporation

 PRESS RELEASE

Atrion Reports Second Quarter 2024 Results

Atrion Reports Second Quarter 2024 Results ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024. Revenues for the second quarter of 2024 totaled $48.8 million compared to $43.8 million for the same period in 2023. For the just ended quarter, operating income was $0.5 million, down $6.8 million from the comparable 2023 period, and net income was $0.4 million, down $6.2 million from the same period in 2023. Operating income was significantly impacted by the accrual of $5.0 million in ac...

 PRESS RELEASE

Atrion Corporation Enters Into Merger Agreement with Nordson Corporati...

Atrion Corporation Enters Into Merger Agreement with Nordson Corporation ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million. The transaction enterprise value reflects a multiple of 20.2 times Atrion’s 2023 EBITDA, and the $460 per share price represen...

 PRESS RELEASE

Atrion Corporation Declares Quarterly Cash Dividend

Atrion Corporation Declares Quarterly Cash Dividend ALLEN, Texas, May 21, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on June 28, 2024 to stockholders of record at the close of business on June 14, 2024. Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is Contact: Cindy FergusonVice President and Chief Financial Officer(972) 390-9800          ...

 PRESS RELEASE

Atrion Reports First Quarter 2024 Results

Atrion Reports First Quarter 2024 Results ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024 totaled $47.3 million compared to $40.0 million for the same period in 2023. For the just ended quarter, operating income was $3.1 million, down $1.3 million from the comparable 2023 period, primarily due to a one-time inventory write-off, and net income was $2.8 million, down $0.7 million from the same period in 2023. First quarter 2024 diluted earnings per...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch